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Abstract
Background: Two-stage revision (TSR) knee arthroplasty is an established treatment, but failure to control infection
still occurs in 4–50 % of cases. The aim of this study was to assess the infection eradication rate, risk factors for
failure, and the clinical outcome after two-stage revision knee arthroplasty.
Methods: This retrospective study included 59 patients who had undergone at least one two-stage revision
procedure due to periprosthetic joint infection (PJI). Demographic data, comorbidities, types of implant, and
complications were analyzed. Univariate and multivariate logistic regression analysis were used to identify risk
factors for failure.
Results: The infections were controlled in 55 patients (93.2 %). The follow-up period was 4.1 (±2.7) years. Infection
control was achieved after the first TSR in 42 patients (71.2 %) and after the second TSR in 13 (76.5 %). The
percentage of arthrodesis procedures in patients with infection control increased from 16.75 % after one TSR to 69.
2 % after two TSRs. Multivariate logistic regression analysis identified body mass index (BMI) (odds ratio 1.22; 95 %
confidence intervals, 1.07 to 1.40; p = 0.004) and smoking (OR 21.52; 95 % CI, 2.60 to 178.19; p = 0.004) as risk factors
for failure.
Conclusions: Two-stage revision protocols can achieve acceptable results even after a second procedure. It is still
unclear whether the choice of implant influences failure rates. Risk factors for failure after two-stage revision were
identified. Studies with larger sample sizes are needed in order to support these findings and identify further risk
factors. To reduce failure rates, programs should be established to treat or minimize risk factors in patients with PJI.
Keywords: Two-stage revision knee arthroplasty, Arthrodesis, Risk factor, Periprosthetic joint infection, BMI, Nicotine
abuse
Abbreviations: BMI, Body mass index; CI, Confidence interval; CRP, C-reactive protein; OR, Odds ratio;
PJI, Periprosthetic joint infection; SD, Standard deviation; TKA, Total knee arthroplasty; TSR, Two-stage revision
Background
Several studies have identified comorbidities and condi-
tions that increase the rate of periprosthetic joint infec-
tion (PJI) after primary hip and knee arthroplasty [1–8].
In two-stage revision (TSR) surgery, protocols involving
the implantation of an antibiotic-loaded bone–cement
spacer have become the gold standard for treating peri-
prosthetic infections.
Radical debridement with explantation of the pros-
thesis and supportive administration of antibiotics are
the most important pillars for controlling PJI [9, 10], but
reinfection rates after TSR continue to be high. Reinfec-
tion rates reported in the literature range from 4 to 50 %
[3, 4, 11–16]. Only a few studies have analyzed the fac-
tors that have a negative impact on infection control
after TSR [17–20]. In order to minimize failure rates in
TSR, evaluated treatment protocols and diagnostic
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algorithms are needed, and it should be possible to iden-
tify patients who are at higher risk of failure. Once risk
factors have been identified, further investigations and
additional treatments can help reduce failure rates.
The aim of the present study was to investigate the ex-
tent to which infection can be successfully controlled
after two-stage revision knee arthroplasty and identify
factors that influence the failure rate.
Methods
Seventy patients who underwent two-stage revision knee
arthroplasty between 2004 and 2008 in our department
were identified. The following criteria were used to de-
fine PJI: sinus tract communicating with the prosthesis
and/or at least two identical positive cultures identified
intraoperatively [21, 22]. All infections were defined as
delayed or late chronic [23].
Seven patients had died and four patients declined to
participate in the study, and a total of 59 patients were
therefore included. Their average age at follow-up was
73 years (±9.7), and there were 32 men and 27 women.
The patients were all referred to our institution as a ter-
tiary center. The protocol consisted of explantation of
the prosthesis with implantation of a fixed antibiotic-
loaded bone–cement spacer (Refobacin® Revision bone ce-
ment; Biomet Inc., Warsaw, Indiana, USA; 1 g gentamicin
and 1 g clindamycin/40 g cement) and at least 14 days of
intravenous antibiotic administration, followed by at least
4 weeks of antibiotics orally. If necessary, additional anti-
biotics were mixed into the spacer, depending on the
microbiological results, as an off-label application. All
antibiotic treatments were administered in collaboration
with the hospital’s Institute of Microbiology. After an
interval of 14 days without antibiotics, C-reactive protein
(CRP) was measured in serum. The second-stage proced-
ure was performed 9–12 weeks after explantation.
The criteria for reimplantation were no sinus track, no
signs of local inflammation, and serum CRP values that
had declined during the period since explantation. The
definition of infection control was no subsequent surgi-
cal intervention for infection at the time of follow-up.
Eleven potential risk factors were documented from the
demographic data, comorbidities, and postoperative
complications.
The criteria for arthrodesis (n = 18 patients) were an
insufficient extension mechanism and/or clearly com-
promised capsule and soft-tissue conditions, with a
high risk of postoperative wound healing problems and
limited function. The indication for arthrodesis was
based on the personal judgment and experience of the
surgeon and the patient’s consent. None of the patients
underwent additional soft-tissue coverage with local
muscle flaps.
Statistical analysis
Means plus or minus standard deviation (SD), ranges,
and proportions were calculated to analyze the different
characteristics in the cases of two-stage knee revision.
Statistical significance was assessed using the chi-
squared test, Fisher’s exact test, Student’s t test, and the
Mann-Whitney U test.
The probability of failed infection control was modeled
using univariate binary logistic regression. Odds ratios,
the corresponding 95 % confidence intervals, and Wald-
type p values were calculated. In a second step, variables
were selected in a stepwise fashion, applying backward
selection to variables in the univariate logistic regression.
All inferential statistics are intended to be exploratory,
not confirmatory, and are interpreted accordingly. The
comparison-wise type 1 error rate is controlled instead
of the experiment-wise error rate. The local significance
level was set to 0.05.
No adjustment for multiple testing was performed.
Statistical analyses were performed using IBM SPSS®
Statistics for Windows, version 21 (IBM Corporation,
Armonk, NY, USA).
Results
Infection control was achieved in 55 patients (93.2 %).
The follow-up period was 4.1 years (±2.7 years). Infec-
tion control was achieved after the first TSR in 42
patients (71.2 %) and after the second TSR in 13 patients
(76.5 %). There were no significant differences between
the first and second TSRs (p > 0.05). The percentage of
arthrodesis in patients with infection control increased
from 16.75 % after one TSR to 69.2 % after two TSRs.
The average time from reimplantation to reinfection was
2.3 years (range 0.6–3.7 years).
The amputation rate when infection could not be con-
trolled was 6.8 % (4/59); amputations were required in
one patient with an arthrodesis and three with revision
endoprostheses. Figure 1 shows the clinical course for all
of the patients. The risk factors investigated and the re-
sults of the univariate logistic regression are listed in
Table 1. Although patients who had Staphylococcus epi-
dermidis at the first revision had the highest failure rate
(35.3 %), statistical analysis was not performed due to
the small number of cases. Table 2 presents the results
of the multivariate logistic regression analysis after vari-
able selection. Table 3 shows the organisms that were
cultured in patients with recurrent infections and the
choice of implant. Identical bacteria were found at the
second TSR in eight of the 17 patients concerned
(47.1 %).
Discussion
Periprosthetic joint infection (PJI) is one of the most se-
vere complications that occur in patients who undergo
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total knee arthroplasty (TKA). Two-stage revision is still
the gold standard for treatment of PJI, although one-
stage revisions may achieve similar results in special
conditions [24–28]. Nevertheless, reinfection rates vary
from 4 to 50 % [3, 4, 11–16]. Among the patients in-
cluded in the present study, successful treatment was
achieved in 55 (93.2 %) after a mean follow-up period of
4.1 years.
There were no differences in the success rates be-
tween patients who underwent one TSR procedure and
those with two procedures. Lower eradication rates
have been reported in the literature after a second TSR
[29], but a high rate of arthrodesis in the second TSRs
might be an explanation for this. Isiklar et al. recom-
mended arthrodesis instead of multiple revisions in
patients with chronic infections, in order to avoid am-
putation [15].
Other studies have also reported higher rates of infec-
tion control with arthrodesis in comparison with revi-
sion prostheses [2, 11, 16, 30]. In contrast to these
results, a 50 % failure rate after septic arthrodesis was
reported in 2015 [31].
In view of the small numbers of arthrodeses, statis-
tical analysis was not carried out in the present study
and no conclusions can therefore be drawn on whether
or not arthrodesis is in fact associated with lower re-
infection rates.
It has to be discussed if allograft reconstruction of
the extensor mechanism is an alternative instead of
arthrodesis. Although it is known that allograft recon-
structions show high rates of complications the
benefit of a better mobility must be considered. In a
study from 2016 in 26 knees, 69 % of the allografts
could be retained at a follow-up of 68 months with a
reoperation rate of 58 % [32, 33].
However, it is not only the type of treatment adminis-
tered that is responsible for the clinical outcome. It is
known from several studies that comorbidities and other
conditions can have a negative influence on infection
rates after primary arthroplasty [1–8]. The causes of fail-
ure after TSR are rarely reported [17–20].
The most frequent potential risk factors for failure
were analyzed in the patients included in the present
study. Among the comorbid conditions present, dia-
betes was identified as a risk factor, with an OR of
6.65 (95 % CI, 1.62 to 27.30) in the univariate ana-
lysis. Another study published in 2015 also found that
diabetes had a significantly higher prevalence in the
group with reinfections [19]. By contrast, Sakellariou
et al. did not find any significant differences in a uni-
variate analysis of 110 patients with TSR [18]. Among
the local conditions that were present, fistulas were
found to be a relevant factor in the univariate ana-
lysis. This finding is supported by a study also pub-
lished in 2015, in which fistulas were associated with
recurrent infection even in the multivariate logistic
regression analysis [20].
A medical history including periprosthetic fracture
around the knee was identified as a risk factor for
failure after the first TSR. In an earlier study, our
group showed that septic failure of revision arthro-
plasty with megaprostheses was strongly associated
Fig. 1 Flowchart of all patients
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with a medical history of periprosthetic fractures
around the knee [13].
Suzuki et al. investigated the influence of surgical
procedures in the region of the knee joint. They ob-
served significantly more frequent infections with open
reduction and internal fixation after trauma to the
knee joint and when osteosynthesis material remained
in situ [7].
Two risk factors were identified in the multivariate lo-
gistic regression analysis in the present study: body mass
index (BMI) and smoking. An increase in the BMI by
Table 1 Potential risk factors for faiure that were investigated with univariable logistic regression
Infection controlled after the first TSR Fialure after the first TSR P value Odds ratio CI (95 %)
Sinus present 0.008 5.24 1.55–17.65
Yes n = 19 N = 10 N = 9
No n = 40 N = 35 N = 5
Diabetes 0.009 6.65 1.62–27.3
Yes n = 11 n = 4 n = 7
No n = 48 n = 38 n = 10
Smoking 0.018 8.33 1.43–48.54
Yes n = 7 N = 3 N = 4
No n = 52 N = 42 N = 10
BMI >30 0.033 5.74 1.15–28.62
Yes n = 37 n = 24 n = 13
No n = 22 n = 17 n = 5
Periprosthetic fracture 0.034 3.57 1.1–11.57
Yes n = 23 n = 14 N = 9
No n = 36 n = 28 N = 8
Wound healing problems 0.061 3.16 0.95–10.55
Yes n = 17 N = 10 N = 7
No n = 42 N = 35 N = 7
Corticosteriods 0.076 8.38 0.8–87.11
Yes n = 4 N = 2 N = 2
No n = 55 N = 43 N = 12
Immune suppression 0.191 5.2 0.44–61.67
Yes N = 1 N = 2
No N = 45 N = 11
Postoperative hematoma 0.418 1.67 0.48–5.8
Yes n = 16 N = 11 N = 5
No n = 43 N = 29 N = 14
Blood transfusion 0.458 2.37 0.24–23.1
Yes n = 44 N = 28 N = 16
No n = 15 N = 14 N = 1
Tumor disease 0.986 1.02 0.18–5.91
Yes n = 7 N = 5 N = 2
No n = 52 N = 40 N = 12
P value, significance level was set to 0.05
Table 2 Comorbid conditions or patterns that were identified
by variable selection as risk factors in a multivariable logistic
regression
P Odds ratio CI (95 %)
Body mass index (kg/m2) 0.004 1.22 1.07–1.40
Nicotine abuse 0.004 21.52 2.60–178.19
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one point showed an increased risk for failure of about
22 %. However, Mortazavi et al. did not observe any as-
sociation between BMI and persistent PJI after two-stage
TKA [25]. Kubista et al. distinguished between BMI
scores of <25, 25–35, and >35.
No significant differences were observed between
these groups with regard to the rates of persistent in-
fection after two-stage TKA [34]. In a matched-cohort
study, patients with a BMI >40 kg/m2 had a 22 % risk
for reinfection in comparison with patients with a
BMI <30 kg/m2, at 4 % [35]. In two-stage revision
hip arthroplasty, obesity has also been found to be a
significant risk factor for failure [36]. Higher rates of
recurrent infection have also been reported among
smokers, with a 71.4 % rate of persistent or recurrent
infection after the first two-stage replacement in com-
parison with only 23.1 % in nonsmokers [6, 7, 37].
These results were confirmed in the present cohort.
The study has several limitations. As all of the pa-
tients were referred to the department, it was not
possible to record all relevant factors. For example,
the number of previous revision procedures was un-
clear and could not be analyzed, although it is known
that this factor has a negative influence on complica-
tion rates [13, 17]. Due to the relatively small number
of patients who underwent arthrodesis, statistical ana-
lysis was not useful. The wide variety of bacteria
identified also made it impossible to carry out statis-
tical analysis.
Conclusions
Two-stage revision (TSR) protocols can achieve accept-
able results even when they are repeated. Amputation
rates can be kept low. It is still unclear whether the
choice of implant has an influence on failure rates. Risk
factors for failure after two-stage revision have been
identified, but studies with larger numbers of patients
are needed in order to support these findings and iden-
tify further risk factors. In order to reduce failure rates,
programs should be established for treating or minimiz-
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